Data / Medical devices / United States / Genmark Diagnostics, Inc.
Genmark Diagnostics, Inc.: FDA-registered device maker in Carlsbad, CA, United States, 5 510(k) clearances
Genmark Diagnostics, Inc. is registered with the FDA (registration 3008632402) in Carlsbad, CA, United States. It lists 15 device types. The FDA files 5 510(k) clearances under its listings, the newest dated April 12, 2019. Registered through 2027. FDA data exported November 2, 2026.
SpecStream is the live web data engine for teams and agents. It reads the FDA registration and listing, 510(k), PMA, recall and enforcement files from openFDA every week, and this page is that reading, joined by the FDA's own numbers. Ask for the makers of any device type in any country and new clearances, approvals and recalls arrive in your sheet, CRM, Slack or agent as the FDA publishes them.
- FDA registration number
- 3008632402
- Address
- GenMark Diagnostics, Inc. 5964 La Place Ct, Carlsbad, CA, United States, 92008
- Owner or operator
- GenMark Diagnostics, Inc. (9056858)
- Roles
- Manufacturer, Manufacturer for export
- First device listed
- June 15, 2017
- Registered through
- 2027
- Brand names listed
- GenMark ePlex Instrument, cobas® eplex blood culture identification fungal pathogen (BCID-FP) panel, cobas® eplex blood culture identification gram negative (BCID-GN) panel, cobas® eplex blood culture identification gram positive (BCID-GP) panel, cobas® eplex respiratory pathogen (RP) panel, cobas® eplex respiratory pathogen panel 2, cobas® eplex respiratory pathogen panel 3, cobas® eplex system and more
Devices it lists
510(k) clearances
The 510(k) numbers this establishment lists, with the FDA decision on each. The applicant is the company that holds the clearance.
| Decided | 510(k) number | Device | Product code | Decision | Applicant | Source |
|---|---|---|---|---|---|---|
| April 12, 2019 | K182619 | ePlex Blood Culture Identification Gram Negative (BCID-GN) Panel | PEN | Substantially Equivalent | Genmark Diagnostics, Incorporated | accessdata.fda.gov |
| December 21, 2018 | K182690 | ePlex Blood Culture Identification Panel Fungal Pathogen (BCID-FP) Panel | PEO | Substantially Equivalent | Genmark Diagnostics, Incorporated | accessdata.fda.gov |
| December 20, 2018 | K181663 | ePlex Blood Culture Identification Panel - Gram Positive (BCID-GP) Panel | PAM | Substantially Equivalent | Genmark Diagnostics, Incorporated | accessdata.fda.gov |
| June 9, 2017 | K163652 | ePlex Instrument | NSU | Substantially Equivalent | Genmark Diagnostics, Incorporated | accessdata.fda.gov |
| June 9, 2017 | K163636 | ePlex Respiratory Pathogen Panel | OCC | Substantially Equivalent | Genmark Diagnostics, Incorporated | accessdata.fda.gov |
Compare with other makers
- All makers of Multi-Target Respiratory Specimen Nucleic Acid Test Including Sars-Cov-2 And Other Microbial Agents
- All makers of Gram-Negative Bacteria And Associated Resistance Markers
- All makers of Fungal Organisms, Nucleic Acid-Based Assay
- All makers of Gram-Positive Bacteria And Their Resistance Markers
- All makers of Instrumentation For Clinical Multiplex Test Systems
- All makers of Reagents, 2019-Novel Coronavirus Nucleic Acid
Updated April 12, 2019. Read from openFDA bulk downloads (device registration and listing, 510(k), PMA, recall and enforcement files). CC0 1.0, public domain (openFDA terms of service). The files are joined on FDA identifiers: the 510(k) and PMA numbers a registration lists, and the recalling firm's FEI for recalls. Recall class comes from the FDA enforcement report. The FDA states that openFDA data is unvalidated and is not for decisions about medical care. Free to reuse with credit to SpecStream under CC BY 4.0. Spot a wrong value? Write to [email protected] with the link to this page.